Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 3/20 | 0.33 |
| ▸ | PRKCG | P05129 | 3/20 | 0.33 |
| ▸ | PRKCB | P05771 | 3/20 | 0.33 |
| ▸ | PRKCA | P17252 | 3/20 | 0.33 |
| ▸ | PRKCH | P24723 | 3/20 | 0.33 |
| ▸ | PRKCI | P41743 | 3/20 | 0.33 |
| ▸ | PRKCE | Q02156 | 3/20 | 0.33 |
| ▸ | PRKCQ | Q04759 | 3/20 | 0.33 |
| ▸ | PRKCZ | Q05513 | 3/20 | 0.33 |
| ▸ | PRKCD | Q05655 | 3/20 | 0.33 |
| ▸ | PRKD1 | Q15139 | 3/20 | 0.33 |
| ▸ | PRKACA | P17612 | 1/20 | 0.33 |
| ▸ | PRKACG | P22612 | 1/20 | 0.33 |
| ▸ | PRKACB | P22694 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL301992 | 0.92 | MEN1 (0.30) | MEN1ALDH1A1CYP2C9CYP2C19KMT2A | |
| SCHEMBL19357602 | 0.84 | PRKD3 (0.34) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| Potassium Ion SCHEMBL9152245 | 0.77 | — | — | |
| SCHEMBL170998 | 0.74 | ALDH1A1 (0.39) | MEN1ALDH1A1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL27426620 | 0.73 | CASP6 (0.38) | MEN1ALDH1A1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL28120681 | 0.70 | MEN1 (0.39) | MEN1ALDH1A1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL2405485 | 0.64 | MEN1 (0.49) | MEN1ALDH1A1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL17145936 | 0.62 | GSK3B (0.45) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL9293198 | 0.62 | CASP6 (0.47) | MEN1ALDH1A1TP53CYP1A2CYP3A4 | |
| SCHEMBL21404284 | 0.61 | CLTC (0.40) | MEN1ALDH1A1CYP2D6CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8133411-B2 | Fluorescent polymers soluble in an aqueous solution and a method for the production thereof | BIOMERIEUX S.A. (FR) | 2012-03-13 | — | — | US | claimed |
| US-20090054532-A1 | Modulators of Retinol-Retinol Binding Protein (RBP)-Transthyretin (TTR) Complex Formation | SIRION THERAPEUTICS, INC. (US) | 2009-02-26 | — | — | US | claimed |
| US-20080290321-A1 | Fluorescent Polymers Soluble in an Aqueous Solution and a Method for the Production Thereof | BIOMERIEUX S.A. (FR) | 2008-11-27 | — | — | US | claimed |
| EP-1899434-A1 | FLUORESCENT POLYMERS SOLUBLE IN AN AQUEOUS SOLUTION AND A METHOD FOR THE PRODUCTION THEREOF | bioMérieux S.A. (FR) | 2008-03-19 | — | — | EP | claimed |
| EP-1807103-A2 | MODULATORS OF RETINOL-RETINOL BINDING PROTEIN (RBP)-TRANSTHYRETIN (TTR) COMPLEX FORMATION | Sirion Therapeutics, Inc. (US) | 2007-07-18 | — | — | EP | claimed |
| WO-2007003781-A1 | FLUORESCENT POLYMERS SOLUBLE IN AN AQUEOUS SOLUTION AND A METHOD FOR THE PRODUCTION THEREOF | BIOMERIEUX S.A. (FR) | 2007-01-11 | — | — | WO | claimed |
| WO-2006052860-A2 | MODULATORS OF RETINOL-RETINOL BINDING PROTEIN (RBP)-TRANSTHYRETIN (TTR) COMPLEX FORMATION | SIRION THERAPEUTICS, INC. (US) | 2006-05-18 | — | — | WO | claimed |
| US-20060094063-A1 | Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation | SYTERA, INC. (US) | 2006-05-04 | — | — | US | claimed |
| WO-2024148174-A1 | PEPTIDE SEQUENCER | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2024-07-11 | — | — | WO | disclosed |
| US-20220389478-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | ORYZON GENOMICS SA (ES) | 2022-12-08 | — | — | US | disclosed |
| US-20220120739-A1 | CHIPS, DETECTORS, AND METHODS OF MAKING AND USING THE SAME | SENTILUS HOLDCO, LLC | 2022-04-21 | — | — | US | disclosed |
| US-11169150-B2 | Chips, detectors, and methods of making and using the same | Sentilus Holdco LLC (US) | 2021-11-09 | — | — | US | disclosed |
| US-11130987-B2 | Direct detection of RNA by surface initiated enzymatic polymerization | SENTILUS HOLDCO, LLC (US) | 2021-09-28 | — | — | US | disclosed |
| US-11034991-B2 | Methods to determine KDM1A target engagement and chemoprobes useful therefor | ORYZON GENOMICS S.A. (ES) | 2021-06-15 | — | — | US | disclosed |
| WO-2007003782-A2 | NOVEL FUNCTIONALISED TRANSFER AGENTS FOR CONTROLLED RADICAL POLYMERISATION RAFT, RAFT METHODS USING SAID TRANSFER AGENTS AND POLYMERS OBTAINABLE THEREBY | BIOMERIEUX S.A. (FR) | 2007-01-11 | — | — | WO | disclosed |
| WO-2007003781-A1 | FLUORESCENT POLYMERS SOLUBLE IN AN AQUEOUS SOLUTION AND A METHOD FOR THE PRODUCTION THEREOF | BIOMERIEUX S.A. (FR) | 2007-01-11 | — | — | WO | disclosed |
| WO-2006052860-A2 | MODULATORS OF RETINOL-RETINOL BINDING PROTEIN (RBP)-TRANSTHYRETIN (TTR) COMPLEX FORMATION | SIRION THERAPEUTICS, INC. (US) | 2006-05-18 | — | — | WO | disclosed |
| US-20060094063-A1 | Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation | SYTERA, INC. (US) | 2006-05-04 | — | — | US | disclosed |
| EP-0938675-B1 | ANALYSIS OF CARBOHYDRATES | AMERSHAM PLC (GB) | 2003-05-07 | — | — | EP | disclosed |
| US-6294667-B1 | SEPARATION OF THE FLUORESCENTLY LABELLED CARBOHYDRATE SUBSTANCES, BY VIRTUE OF THEIR DIFFERENT CHARGE-TO-MASS RATIOS OR OTHER FACTORS, ENABLING A LARGER NUMBER OF DIFFERENT LABELLED CARBOHYDRATE SUBSTANCES TO BE SEPARATED | AMERSHAM INTERNATIONAL PLC | 2001-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220389478-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | KDM1B, KDM1A, KDM7A | PRKD3 2164/4885PRKCG 1318/4885PRKCB 586/4885 |
| US-20090054532-A1 | Modulators of Retinol-Retinol Binding Protein (RBP)-Transthyretin (TTR) Complex Formation | RBP1, TTR, RBP4 | PRKD3 3548/4885PRKCG 2427/4885PRKCB 2262/4885 |
| US-20060094063-A1 | Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation | RBP1, TTR, RBP4 | PRKD3 3548/4885PRKCG 2427/4885PRKCB 2262/4885 |
| US-11034991-B2 | Methods to determine KDM1A target engagement and chemoprobes useful therefor | KDM1B, KDM1A, KDM7A | PRKD3 2164/4885PRKCG 1318/4885PRKCB 586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.